Tern Plc comments on significant rise in the share price of Wyld Networks AB

Tern - Wyld Networks

Tern Plc (LON:TERN), the company focused on value creation from Internet of Things (“IoT”) technology businesses, has noted the recent rise in the Company’s share price. The Board also notes today’s significant rise in the share price of Wyld Networks AB. Wyld Networks has published a press release today in relation to the signing of an agreement with SpaceX to discuss potential areas of collaboration.

Wyld Networks is a portfolio company of Tern’s in which Tern currently owns approximately 27%.

Extracted from a translation of the Wyld Networks press release:

“Space X offers satellite connectivity for broadband through Starlink and connectivity for IoT through Swarm. Wyld and SpaceX will explore potential areas of collaboration to collect data from IoT sensors in remote locations.

Satellite connectivity can help bridge the digital divide and increase the reach and resilience of connections for IoT devices. This is particularly the case for the 85% of the Earth’s surface that has no cellular coverage.

Both SpaceX and Wyld Networks operate on low-bandwidth satellite connectivity using satellites orbiting in low orbit. These satellites cover every point on Earth, enabling IoT devices to operate and deliver data at an affordable price, anywhere on Earth.

SpaceX and Wyld will initially explore the potential of offering remote connectivity in North, Central and South America.

Wyld Networks’ IoT engineering team is a leader in delivering satellite IoT connectivity solutions. Their innovative technology leads to exceptional performance with satellites orbiting the Earth in low Earth orbit.

“We are excited to explore possible areas with SpaceX where our technology can enable additional connectivity and access to data from sensors and devices in remote locations,” said Alastair Williamson, CEO Wyld Networks. “With Wyld Connect available to deliver data from IoT devices anywhere on Earth, this is a great opportunity to partner with the world’s most important satellite companies.””

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Talking Medicines highlights strategic signals emerging across the GLP-1 consumer market

GLP-1 consumers are increasingly weighing access, affordability, quality, clinical oversight and treatment support, creating new strategic considerations across the wider life sciences market.

Tern Plc launches £509,368 underwritten Open Offer

Tern Plc has announced an underwritten Open Offer to raise approximately £509,368 through the issue of 56.6 million shares at 0.90p each. Qualifying shareholders may subscribe for one new share for every 16 shares held, with the offer closing on 22 September 2026.

Talking Medicines targets a growing data need around GLP-1 treatment journeys

Talking Medicines is using GLP-1 discontinuation conversations to show how DrugVoice can help pharmaceutical companies track changing patient needs across the treatment journey.

Device Authority adopts usage-based pricing to support KeyScaler expansion

Device Authority has moved KeyScaler to usage-based pricing, aiming to reduce licensing friction and support broader adoption of its machine identity security platform.

Talking Medicines targets growing demand for GLP-1 patient intelligence

Talking Medicines is using GLP-1 patient conversations to show how behavioural data can help pharmaceutical companies understand changing treatment expectations and engagement.

Talking Medicines builds its AI strategy around specialist life sciences intelligence

Talking Medicines is positioning specialist healthcare intelligence as the core layer that gives agentic AI useful context in life sciences.

Search